Impact of Positive Culture Reports of E. coli or MSSA on De-Escalation of Antibiotic Use in a Teaching Hospital in Pakistan and the Implications

References

• CDC International. Conference on Emerging Infectious Diseases; 2018.
   Google Scholar
• Saleem Z, Saeed H, Hassali MA, et al. Pattern of inappropriate antibiotic use among hospitalized patients in Pakistan: a longitudinal surveillance and implications. Antimicrob Resist Infect Control. 2019;8(1):188. doi:10.1186/s13756-019-0649-5
   PubMed Web of Science ®Google Scholar
• Saleem Z, Hassali MA. Travellers take heed: outbreak of extensively drug resistant (XDR) typhoid fever in Pakistan and a warning from the US CDC. Travel Med Infect Dis. 2019;27:127. doi:10.1016/j.tmaid.2018.10.013
   PubMed Web of Science ®Google Scholar
• Almangour TA, Alenazi B, Ghonem L, Alhifany AA, Aldakheel BA, Alruwaili A. Inhaled colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: a real-life experience in tertiary care hospitals in Saudi Arabia. Saudi Pharma J. 2020;28(8):1009–1013. doi:10.1016/j.jsps.2020.06.023
   PubMed Web of Science ®Google Scholar
• Alghamdi M, Alotaibi F, Ahmed H, Alharbi F, Bukhari O, Youssef A-R. Effect of medical education on the knowledge, attitude and compliance regarding infection control measures among dental students in Makkah. J Umm Al-Qura Univ Med Sci. 2021;7(1):14–17. doi:10.54940/ms31191227
   Google Scholar
• Almeleebia TM, Alhifany AA, Almutairi F, Alshibani M, Alhossan AM. Regulating antimicrobial sales in Saudi Arabia: achievements and challenges. Int J Clin Pract. 2021;75(4):e13833. doi:10.1111/ijcp.13833
   PubMed Web of Science ®Google Scholar
• Rolain J-M, Abat C, Jimeno M-T, Fournier P-E, Raoult D. Do we need new antibiotics? Clin Microbiol Infect. 2016;22(5):408–415. doi:10.1016/j.cmi.2016.03.012
   PubMed Web of Science ®Google Scholar
• Pollack LA, Srinivasan A. Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention. Clin Infect Dis. 2014;59(suppl_3):S97–S100. doi:10.1093/cid/ciu542
   PubMed Web of Science ®Google Scholar
• Brodt H-R, Brodt H-R, Brodt H-R, et al. Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases. Infection. 2016;44(3):395–439. doi:10.1007/s15010-016-0885-z
   Web of Science ®Google Scholar
• Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN. The Alexander Project 1998–2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother. 2003;52(2):229–246. doi:10.1093/jac/dkg321
   PubMed Web of Science ®Google Scholar
• Agaba P, Tumukunde J, Tindimwebwa J, Kwizera A. Nosocomial bacterial infections and their antimicrobial susceptibility patterns among patients in Ugandan intensive care units: a cross sectional study. BMC Res Notes. 2017;10(1):1–12. doi:10.1186/s13104-017-2695-5
   Google Scholar
• Morel J, Casoetto J, Jospé R, et al. De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit. Crit Care. 2010;14(6):1–7.
   Web of Science ®Google Scholar
• Palavecino EL, Williamson JC, Ohl CA. Collaborative antimicrobial stewardship: working with microbiology. Infect Dis Clin North Am. 2020;34(1):51. doi:10.1016/j.idc.2019.10.006
   Web of Science ®Google Scholar
• Leeman HM, Chan BP, Zimmermann CR, et al. Creation of state antibiogram and subsequent launch of public health–coordinated antibiotic stewardship in new hampshire: small state, big collaboration. Public Health Rep. 2021;2021:0033354921995778.
   Google Scholar
• Moraes RB, Guillén JAV, Zabaleta W, Borges FK. De-escalation, adequacy of antibiotic therapy and culture positivity in septic patients: an observational study. Revista Brasileira de terapia intensiva. 2016;28(3):315–322. doi:10.5935/0103-507X.20160044
   PubMedGoogle Scholar
• Moehring RW, Ashley ED, Davis AE, et al. Development of an electronic definition for de-escalation of antibiotics in hospitalized patients. 2020.
   Google Scholar
• Dellit TH, Owens RC, McGowan JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159–177. doi:10.1086/510393
   PubMed Web of Science ®Google Scholar
• Younis BB, Rozina A, Junaid M, Saima K, Farhan N, Maham T. A Study of Unnecessary Use of Antibiotics at a Tertiary care hospital: urgent need to implement antimicrobial stewardship programs. J Young Pharma. 2015;7(4):311. doi:10.5530/jyp.2015.4.5
   Google Scholar
• Liu P, Ohl C, Johnson J, Williamson J, Beardsley J, Luther V. Frequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program. BMC Infect Dis. 2016;16(1):1–7.
   Google Scholar
• Ohji G, Doi A, Yamamoto S, Iwata KJ. Is de-escalation of antimicrobials effective? A systematic review and meta-analysis. Int J Infect Dis. 2016;49:71–79. doi:10.1016/j.ijid.2016.06.002
   PubMed Web of Science ®Google Scholar
• Mokart D, Slehofer G, Lambert J, et al. De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study. Intensive Care Med. 2014;40(1):41–49. doi:10.1007/s00134-013-3148-9
   PubMed Web of Science ®Google Scholar
• Knaak E, Cavalieri SJ, Elsasser GN, Preheim LC, Gonitzke A, Destache CJ. Does antibiotic de-escalation for nosocomial pneumonia impact intensive care unit length of stay? Infect Dis Clin Pract. 2013;21(3):172–176.
   Google Scholar
• Guo Y, Gao W, Yang H, Sui SJH, Sui S. De-escalation of empiric antibiotics in patients with severe sepsis or septic shock: a meta-analysis. Heart Lung. 2016;45(5):454–459. doi:10.1016/j.hrtlng.2016.06.001
   PubMed Web of Science ®Google Scholar
• Khasawneh FA, Karim A, Mahmood T, Ahmed S, Jaffri SF, Mehmood M. Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia. Infect Drug Resist. 2014;7:177. doi:10.2147/IDR.S65928
   PubMed Web of Science ®Google Scholar
• Hadi MA, Karami NA, Al-Muwalid AS, et al. Community pharmacists’ knowledge, attitude, and practices towards dispensing antibiotics without prescription (DAwP): a cross-sectional survey in Makkah Province, Saudi Arabia. Int J Infect Dis. 2016;47:95–100. doi:10.1016/j.ijid.2016.06.003
   PubMed Web of Science ®Google Scholar
• Masterton RG. Antibiotic de-escalation. Crit Care Clin. 2011;27(1):149–162. doi:10.1016/j.ccc.2010.09.009
   PubMed Web of Science ®Google Scholar
• Bal AM, Gould IM. Antibiotic stewardship: overcoming implementation barriers. Curr Opin Infect Dis. 2011;24(4):357–362. doi:10.1097/QCO.0b013e3283483262
   PubMed Web of Science ®Google Scholar
• Gonzalez L, Cravoisy A, Barraud D, et al. Factors influencing the implementation of antibiotic de-escalation and impact of this strategy in critically ill patients. Crit Care. 2013;17(4):R140. doi:10.1186/cc12819
   PubMed Web of Science ®Google Scholar
• Almangour TA, Perry GK, Terriff CM, Alhifany AA, Kaye KS. Dalbavancin for the management of gram-positive osteomyelitis: effectiveness and potential utility. Diagn Microbiol Infect Dis. 2019;93(3):213–218. doi:10.1016/j.diagmicrobio.2018.10.007
   PubMed Web of Science ®Google Scholar
• Vila J, Sáez-López E, Johnson JR, et al. Escherichia coli: an old friend with new tidings. FEMS Microbiol Rev. 2016;40(4):437–463. doi:10.1093/femsre/fuw005
   PubMed Web of Science ®Google Scholar
• Lindsay JA. Hospital-associated MRSA and antibiotic resistance—What have we learned from genomics? Int J Med Microbiol. 2013;303(6–7):318–323. doi:10.1016/j.ijmm.2013.02.005
   PubMed Web of Science ®Google Scholar
• Otto M. Community-associated MRSA: what makes them special? Int J Med Microbiol. 2013;303(6–7):324–330. doi:10.1016/j.ijmm.2013.02.007
   PubMed Web of Science ®Google Scholar
• Harada K, Asai T. Role of antimicrobial selective pressure and secondary factors on antimicrobial resistance prevalence in Escherichia coli from food-producing animals in Japan. Biomed Res Int. 2010;2010:115.
   Google Scholar
• Ibrahim EH, Ward S, Sherman G, Schaiff R, Fraser VJ, Kollef MH. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med. 2001;29(6):1109–1115. doi:10.1097/00003246-200106000-00003
   PubMed Web of Science ®Google Scholar
• Saleem Z, Hassali MA, Versporten A, Godman B. A multicenter point prevalence survey of antibiotic use in Punjab, Pakistan: findings and implications. Expert Rev Anti Infect Ther. 2019;17(4):285–293. doi:10.1080/14787210.2019.1581063
   PubMed Web of Science ®Google Scholar
• Saleem Z, Hassali MA, Hashmi FK, Godman B, Ahmed Z. Snapshot of antimicrobial stewardship programs in the hospitals of Pakistan: findings and implications. Heliyon. 2019;5(7):e02159. doi:10.1016/j.heliyon.2019.e02159
   PubMed Web of Science ®Google Scholar
• Mubarak N, Khan AS, Zahid T, et al. Assessment of adherence to the core elements of hospital antibiotic stewardship programs: a survey of the tertiary care hospitals in Punjab, Pakistan. Antibiotics. 2021;10(8):906. doi:10.3390/antibiotics10080906
   Google Scholar
• Saleem Z, Godman B, Azhar F, et al. Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications. Expert Rev Anti Infect Ther. 2022;20(1):71–93. doi:10.1080/14787210.2021.1935238
   PubMed Web of Science ®Google Scholar
• Khan RA, Aziz Z. Antibiotic de-escalation therapy in neurosurgical patients with ventilator-associated pneumonia in Intensive Care Unit: a retrospective observational study. Indian J Pharm Educ Res. 2017;51:144–149.
   Web of Science ®Google Scholar
• Almangour TA, Ghonem L, Aljabri A, et al. Ceftazidime-avibactam versus colistin for the treatment of infections due to carbapenem-resistant Enterobacterales: a multicenter cohort study. Infect Drug Resist. 2022;15:211. doi:10.2147/IDR.S349004
   PubMed Web of Science ®Google Scholar
• Choudhary S, Yadav AK, Sharma S, Pichholiya M, Sharma P. Effect of blood culture reports on antibiotics use by physicians in septic patients of intensive care unit. Int J Res Med Sci. 2015;3(9):2425.
   Google Scholar
• Afriyie DK, Sefah IA, Sneddon J, et al. Antimicrobial point prevalence surveys in two Ghanaian hospitals: opportunities for antimicrobial stewardship. JAC Antimicrob Resist. 2020;2(1):dlaa001. doi:10.1093/jacamr/dlaa001
   PubMedGoogle Scholar
• Ogunleye OO, Oyawole MR, Odunuga PT, et al. A multicentre point prevalence study of antibiotics utilization in hospitalized patients in an urban secondary and a tertiary healthcare facilities in Nigeria: findings and implications. Expert review of anti-infective therapy. Expert Rev Anti-Infect Ther. 2022;20(2):297–306. doi:10.1080/14787210.2021.1941870
   PubMed Web of Science ®Google Scholar
• Kurdi A, Hasan AJ, Baker KI, et al. A multicentre point prevalence survey of hospital antibiotic prescribing and quality indices in the Kurdistan Regional Government of Northern Iraq: the need for urgent action. Expert Rev Anti Infect Ther. 2021;19(6):805–814. doi:10.1080/14787210.2021.1834852
   PubMed Web of Science ®Google Scholar
• Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. Pharma Therap. 2015;40(4):277.
   Google Scholar
• Murray CJ, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–655. doi:10.1016/S0140-6736(21)02724-0
   PubMed Web of Science ®Google Scholar
• Hofer U. The cost of antimicrobial resistance. Nat Rev Microbiol. 2019;17(1):3. doi:10.1038/s41579-018-0125-x
   PubMedGoogle Scholar
• Jabeen K, Zafar A, Hasan R. Frequency and sensitivity pattern of extended spectrum beta lactamase producing isolates in a tertiary care hospital laboratory of Pakistan. J Pak Med Assoc. 2005;55(10):436.
   PubMedGoogle Scholar
• Dlamini NN, Meyer JC, Kruger D, Kurdi A, Godman B, Schellack N. Feasibility of using point prevalence surveys to assess antimicrobial utilisation in public hospitals in South Africa: a pilot study and implications. Hosp Pract. 2019;47(2):88–95. doi:10.1080/21548331.2019.1592880
   PubMedGoogle Scholar
• Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51–e77. doi:10.1093/cid/ciw118
   PubMed Web of Science ®Google Scholar
• Nathwani D, Varghese D, Stephens J, Ansari W, Martin S, Charbonneau C. Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review. Antimicrob Resist Infect Control. 2019;8(1):1–13. doi:10.1186/s13756-019-0471-0
   PubMed Web of Science ®Google Scholar
• Khan EA, Owens RC, McGowan JE. An urgent need for national action plan for infection control and antibiotic stewardship in Pakistan. Clin Infect Dis. 2007;44:159–177.
   PubMedGoogle Scholar
• Latha T, Anil B, Manjunatha H, et al. MRSA: the leading pathogen of orthopedic infection in a tertiary care hospital, South India. African Health Sci. 2019;19(1):1393–1401.
   Web of Science ®Google Scholar
• Kibret M, Abera B. Antimicrobial susceptibility patterns of E. Coli from Clinical Sources in Northeast Ethiopia. African Health Sci. 2011;11:40–45.
   Web of Science ®Google Scholar
• Mir F, Rashid A, Farooq M, Irfan M, Ijaz A. Antibiotic sensitivity patterns of staphylococcal skin infections. J Pak Assoc Dermatol. 2016;25(1):12–17.
   Google Scholar
• Hanif MM, Butt T, Amjad M. Pathogens involved and antibiotic sensitivity pattern of isolates in community acquired common bacterial skin infections presenting in a tertiary care hospital. Pak Armed Forces Med J. 2006;56(3):289–294.
   Google Scholar
• Onwubiko NE, Sadiq NM. Antibiotic sensitivity pattern of Staphylococcus aureus from clinical isolates in a tertiary health institution in Kano, Northwestern Nigeria. Pan African Med J. 2011;8(1). doi:10.4314/pamj.v8i1.71050
   Google Scholar